Okai, A. F., Amezcua, L., Berkovich, R. R., Chinea, A. R., Edwards, K. R., Steingo, B., . . . Williams, M. J. (2019). Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study). Neurol Ther.
استشهاد بنمط شيكاغوOkai, Annette F., et al. "Efficacy and Safety of Alemtuzumab in Patients of African Descent With Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)." Neurol Ther 2019.
MLA استشهادOkai, Annette F., et al. "Efficacy and Safety of Alemtuzumab in Patients of African Descent With Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)." Neurol Ther 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.